Intravenous iron administration is associated with reduced platelet counts in patients with chronic kidney disease

Iron dosing in kidney disease: inconsistency of evidence and clinical practice

(2014) A. E. Gaweda et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mechanisms of Anemia in CKD

(2012) J. L. Babitt et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

(2011) David H. Henry et al.   AMERICAN JOURNAL OF HEMATOLOGY

Efficacy and Tolerability of Accelerated-Dose Low-Molecular-Weight Iron Dextran (Cosmofer) in Patients with Chronic Kidney Disease

(2011) M. Cooke et al.   AMERICAN JOURNAL OF NEPHROLOGY

Regulation of cellular iron metabolism

(2011) Jian Wang et al.   BIOCHEMICAL JOURNAL

Iron supplementation to treat anemia in patients with chronic kidney disease

(2010) Anatole Besarab et al.   Nature Reviews Nephrology

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome

(2009) A. Besarab et al.   ONCOLOGIST

Editorial Focus: Thrombosis with Erythropoietic Stimulating Agents-Does Iron-Deficient Erythropoiesis Play a Role?

(2008) Naomi V. Dahl et al.   SEMINARS IN DIALYSIS